Product Name

  • Name

    Artemisinin

  • EINECS 1806241-263-5
  • CAS No. 63968-64-9
  • Article Data61
  • CAS DataBase
  • Density 1.24 g/cm3
  • Solubility
  • Melting Point 156-157 oC
  • Formula C15H22O5
  • Boiling Point 389.9oC at 760 mmHg
  • Molecular Weight 282.337
  • Flash Point 172oC
  • Transport Information
  • Appearance Crystalline Solid
  • Safety 22-24/25
  • Risk Codes
  • Molecular Structure Molecular Structure of 63968-64-9 (Artemisinin)
  • Hazard Symbols
  • Synonyms (+)-Arteannuin;Qinghaosu;[3R-(3R,5aS,6S,8aS,9R,10R,12S,12aR**)]-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-one;
  • PSA 53.99000
  • LogP 2.39490

Synthetic route

(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl carbamate

(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl carbamate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With [bis(acetoxy)iodo]benzene; magnesium oxide; Rh2(fb)4 In dichloromethane for 24h; Heating;96%
4α-hydroperoxy-amorph-5-en-12-oic acid
85031-60-3

4α-hydroperoxy-amorph-5-en-12-oic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one
104196-16-9

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid In toluene Flow reactor; chemoselective reaction;A 81%
B 7%
4-chloro-3-nitrobenzoate
96-99-1

4-chloro-3-nitrobenzoate

7β-hydroxyartemisinin

7β-hydroxyartemisinin

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; for 12h; Inert atmosphere;75%
4α-hydroperoxy-amorph-5-en-12-oic acid
85031-60-3

4α-hydroperoxy-amorph-5-en-12-oic acid

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; copper(I) triflate at 20℃; Temperature;65%
(3R)-dihydroarteannuin B acid methyl carbonate
1267472-30-9

(3R)-dihydroarteannuin B acid methyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;62.2%
(3R)-dihydroarteannuin B acid ethyl carbonate
1267472-33-2

(3R)-dihydroarteannuin B acid ethyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;62%
With 5,10,15,20-tetraphenyl-21H,23H-porphine; trifluoroacetic acid In dichloromethane at -15 - -10℃; Irradiation; Industrial scale;370 kg
(3R)-dihydroarteannuin B acid benzyl carbonate
1267472-35-4

(3R)-dihydroarteannuin B acid benzyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;59.2%
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

arteanniun H
207446-83-1

arteanniun H

Conditions
ConditionsYield
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane Irradiation; High pressure;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane; toluene at 25℃; for 0.333333h;
A 59.1%
B 6.1%
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / -20 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 0.33 h / 25 °C / 750.08 Torr / Flow reactor
View Scheme
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / -20 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 0.33 h / 50 °C / 750.08 Torr / Flow reactor
View Scheme
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / 60 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 0.33 h / 25 °C / 750.08 Torr / Flow reactor
View Scheme
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / 60 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 0.33 h / 50 °C / 750.08 Torr / Flow reactor
View Scheme
(3R)-dihydroarteannuin B acid 2,2,2-trichloroethyl carbonate
1267472-31-0

(3R)-dihydroarteannuin B acid 2,2,2-trichloroethyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;58.7%
(3R)-dihydroarteannuin B acid phenyl carbonate
1267472-37-6

(3R)-dihydroarteannuin B acid phenyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;58.4%
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(4R,4aS,7R,8S)-4,7-Dimethyl-8-(3-oxo-butyl)-4,4a,5,6,7,8-hexahydro-isochromen-3-one
105231-07-0

(4R,4aS,7R,8S)-4,7-Dimethyl-8-(3-oxo-butyl)-4,4a,5,6,7,8-hexahydro-isochromen-3-one

Conditions
ConditionsYield
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane Irradiation; High pressure;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane; toluene at 0℃; for 1h; Solvent; Temperature; Time;
A 55.6%
B 6.8%
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane Irradiation; High pressure;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane; toluene at -15℃; for 0.333333h;
A 18%
B 21.3%
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / -20 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 1 h / 0 °C / 750.08 Torr / Flow reactor
View Scheme
Multi-step reaction with 2 steps
1: 5,15,10,20-tetraphenylporphyrin; oxygen / dichloromethane / 60 °C / Flow reactor; UV-irradiation
2: trifluoroacetic acid; oxygen / toluene / 1 h / 0 °C / 750.08 Torr / Flow reactor
View Scheme
(3R)-dihydroarteannuin B acid 2-chloroethyl carbonate
1267472-43-4

(3R)-dihydroarteannuin B acid 2-chloroethyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;54.9%
(3R)-dihydroarteannuin B acid propyl carbonate
1267472-39-8

(3R)-dihydroarteannuin B acid propyl carbonate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With oxygen; trifluoroacetic acid; 5,10,15,20-tetraphenyl-21H,23H-porphine In dichloromethane at -10 - 20℃; for 22h; Photochemical reaction;54.5%
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane under 8625.86 Torr;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane at 0℃; for 2h;
50%
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane under 8625.86 Torr; UV-irradiation;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane at 0℃; under 760.051 Torr; for 2h; Pressure; Temperature; Solvent;
50%
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane at 0℃; under 760.051 Torr; for 0.0333333h;
Stage #2: With trifluoroacetic acid In dichloromethane at 0℃; for 2h; Time; Temperature; Concentration; UV-irradiation;
50%
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With porphyrin; trifluoroacetic acid In toluene at 25℃; Temperature; Reagent/catalyst; Irradiation;50%
(+)-deoxoartemisinin
126189-95-5

(+)-deoxoartemisinin

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With ruthenium trichloride; sodium periodate49%
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one
104196-16-9

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one

C

arteanniun H
207446-83-1

arteanniun H

Conditions
ConditionsYield
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane Irradiation; High pressure;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane; toluene at 50℃; for 0.333333h;
A 47%
B 5.5%
C 7.2%
5α-hydroperoxy-amorph-5-en-12-oic acid methyl ester
85031-63-6

5α-hydroperoxy-amorph-5-en-12-oic acid methyl ester

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(R)-2-((4R,4aS)-4,7-Dimethyl-2,3,4,4a,5,6-hexahydro-naphthalen-1-yl)-propionic acid methyl ester

(R)-2-((4R,4aS)-4,7-Dimethyl-2,3,4,4a,5,6-hexahydro-naphthalen-1-yl)-propionic acid methyl ester

C

(R)-2-[(1S,3S,4R)-2-Formyl-2-[(2R,4aS,5R,8S)-8-((R)-1-methoxycarbonyl-ethyl)-2,5-dimethyl-2,3,4,4a,5,6,7,8-octahydro-naphthalen-2-ylperoxy]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester
422565-48-8

(R)-2-[(1S,3S,4R)-2-Formyl-2-[(2R,4aS,5R,8S)-8-((R)-1-methoxycarbonyl-ethyl)-2,5-dimethyl-2,3,4,4a,5,6,7,8-octahydro-naphthalen-2-ylperoxy]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

D

(R)-2-[(1S,3S,4R)-2-Formyl-2-[(2S,3R,6S)-6-((R)-1-methoxycarbonyl-ethyl)-3-methyl-2-(3-oxo-butyl)-cyclohex-(E)-ylidenemethoxy]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

(R)-2-[(1S,3S,4R)-2-Formyl-2-[(2S,3R,6S)-6-((R)-1-methoxycarbonyl-ethyl)-3-methyl-2-(3-oxo-butyl)-cyclohex-(E)-ylidenemethoxy]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

Conditions
ConditionsYield
In chloroform-d1 for 2556.75h; Further byproducts given;A 3%
B 40%
C 4%
D n/a
dihydroartemisinic acid
85031-59-0, 110715-68-9, 126643-10-5

dihydroartemisinic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one
104196-16-9

(3R,3a,6R,6aS,10aS)-3a,4,5,6,6a,7,8,8a-octahydro-3,6,9-trimethylnaphtho[8a,1-b]furan-2(3H)-one

C

(4R,4aS,7R,8S)-4,7-Dimethyl-8-(3-oxo-butyl)-4,4a,5,6,7,8-hexahydro-isochromen-3-one
105231-07-0

(4R,4aS,7R,8S)-4,7-Dimethyl-8-(3-oxo-butyl)-4,4a,5,6,7,8-hexahydro-isochromen-3-one

D

arteanniun H
207446-83-1

arteanniun H

Conditions
ConditionsYield
Stage #1: dihydroartemisinic acid With oxygen; 5,15,10,20-tetraphenylporphyrin In dichloromethane Irradiation; High pressure;
Stage #2: With oxygen; trifluoroacetic acid In dichloromethane; toluene at 75℃; for 0.333333h;
A 31.2%
B 6.1%
C 9.6%
D 7.5%
4-((7R,8S)-3-methoxy-4,7-dimethyl-3-((triisopropylsilyl)oxy)-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl)butan-2-one
1393603-22-9

4-((7R,8S)-3-methoxy-4,7-dimethyl-3-((triisopropylsilyl)oxy)-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl)butan-2-one

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
Stage #1: 4-((7R,8S)-3-methoxy-4,7-dimethyl-3-((triisopropylsilyl)oxy)-4,4a,5,6,7,8-hexahydro-3H-isochromen-8-yl)butan-2-one With ammonium molibdate; dihydrogen peroxide In water; tert-butyl alcohol at 20℃; for 72h;
Stage #2: With toluene-4-sulfonic acid In dichloromethane at 20℃; for 72h;
29%
(R)-2-[(1S,3S,4R)-2-[1-Methoxy-meth-(Z)-ylidene]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester
87322-20-1

(R)-2-[(1S,3S,4R)-2-[1-Methoxy-meth-(Z)-ylidene]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
Stage #1: (R)-2-[(1S,3S,4R)-2-[1-Methoxy-meth-(Z)-ylidene]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester With hydrogenchloride; oxygen; rose bengal In methanol at -78℃; for 4h; UV-irradiation;
Stage #2: With perchloric acid for 28h;
10%
dehydroqinghaosu
101020-89-7

dehydroqinghaosu

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(+)-9-epiartemisinin
113472-97-2

(+)-9-epiartemisinin

C

9β-hydroxydeoxy-11-epi-artemisinin

9β-hydroxydeoxy-11-epi-artemisinin

D

9β-hydroxy-11-epi-artemisinin

9β-hydroxy-11-epi-artemisinin

Conditions
ConditionsYield
With Aspergillus niger NRRL 599; culture medium In water; acetone at 25℃; for 240h; Hydrogenation; oxidation; deoxygenation;A n/a
B 8.9%
C 5.5%
D 7.1%
artemisinic acid
80286-58-4

artemisinic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-methylidene-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one
50906-56-4

(1R,5S,8R,9S,12R,14R)-8,12-dimethyl-4-methylidene-2,13-dioxatetracyclo[7.5.0.01,5.012,14]tetradecan-3-one

Conditions
ConditionsYield
In water at 30℃; for 2h; cell-free extract from Artemisia annua L. (Asteraceae), EDTA, HEPES with DDT buffer, pH 7.15; Title compound not separated from byproducts;
(2R,1'S,3'S,4'S)-2-<4'-methyl-3'-(3''-oxobutyl)-2'(E)-<(trimethylsilyl)methylene>cyclohexyl>propionic acid
116399-93-0

(2R,1'S,3'S,4'S)-2-<4'-methyl-3'-(3''-oxobutyl)-2'(E)-<(trimethylsilyl)methylene>cyclohexyl>propionic acid

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With ozone; trifluoroacetic acid 1.) MeOH, -78 deg C, 2.) CHCl3, H2O; Yield given. Multistep reaction;
(2R,1'S,3'S,4'S)-2-<4'-methyl-3'-(3''-oxobutyl)-2'(E)-<(trimethylsilyl)methylene>cyclohexyl>propionic acid
116399-93-0

(2R,1'S,3'S,4'S)-2-<4'-methyl-3'-(3''-oxobutyl)-2'(E)-<(trimethylsilyl)methylene>cyclohexyl>propionic acid

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

2-deoxyartemisinin
72826-63-2

2-deoxyartemisinin

Conditions
ConditionsYield
With oxygen; ozone; trifluoroacetic acid 1.) CH2Cl2, -78 deg C, 2.) CDCl3; Yield given. Multistep reaction. Yields of byproduct given;
2,5,5-trimethyl-2-<2'-<4''-(1(S)-carboxyethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane
116400-02-3

2,5,5-trimethyl-2-<2'-<4''-(1(S)-carboxyethyl)-1''(R)-methyl-3''-<(trimethylsilyl)methylene>cyclohex-2''-yl>ethyl>-1,3-dioxane

A

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

B

2-deoxyartemisinin
72826-63-2

2-deoxyartemisinin

Conditions
ConditionsYield
With 2,6-di-tert-butyl-4-methyl-phenol; sulfuric acid; oxygen; silica gel; ozone 1.) CH2Cl2, -78 deg C, 2 min, 2.) CH2Cl2, 22 deg C, overnight; Yield given. Multistep reaction. Yields of byproduct given;
Sodium; (R)-2-[(1S,3S,4R)-2-[1-methoxy-meth-(Z)-ylidene]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionate

Sodium; (R)-2-[(1S,3S,4R)-2-[1-methoxy-meth-(Z)-ylidene]-4-methyl-3-(3-oxo-butyl)-cyclohexyl]-propionate

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
With formic acid; oxygen 1.) MeOH, irradiation, -78 ded C, 2.) CH2Cl2, 0 deg C, 24 h; Yield given;
Benzoic acid (2R,4aR,5R,8R,8aS)-5-((R)-1-methoxycarbonyl-ethyl)-3,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydro-naphthalen-2-yl ester

Benzoic acid (2R,4aR,5R,8R,8aS)-5-((R)-1-methoxycarbonyl-ethyl)-3,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydro-naphthalen-2-yl ester

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

Conditions
ConditionsYield
Yield given. Multistep reaction;
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

dihydroartemisinin
71939-50-9

dihydroartemisinin

Conditions
ConditionsYield
With diisobutylaluminium hydride In dichloromethane at -78℃; for 1.25h;100%
With methanol; sodium tetrahydroborate at 0℃; for 3h; Inert atmosphere;100%
With sodium tetrahydroborate In methanol at 0 - 20℃; for 0.5h; Inert atmosphere; Green chemistry;98%
With sodium tetrahydroborate In methanol at 0℃; for 1h;91%
With sodium tetrahydroborate In methanol at 0 - 5℃; for 3h;79%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

dihydroartesiminin
81496-81-3

dihydroartesiminin

Conditions
ConditionsYield
With sodium tetrahydroborate; N-benzyl-N,N,N-triethylammonium chloride In water; toluene at -10 - 0℃; for 5h; Solvent; Inert atmosphere; Large scale;99.6%
With sodium tetrahydroborate In methanol at 0℃;
With diisobutylaluminium hydride at -78℃;
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

dihydroartemisinin
71939-50-9

dihydroartemisinin

Conditions
ConditionsYield
With methanol; sodium tetrahydroborate at 0℃; for 3h;98%
With sodium tetrahydroborate In methanol at 0 - 5℃; for 3.33333h;97.15%
With sodium tetrahydroborate In methanol for 1.25h;96%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

2-deoxyartemisinin
72826-63-2

2-deoxyartemisinin

Conditions
ConditionsYield
With zinc In acetic acid for 2.5h; Ambient temperature;98%
With hydrogen; Lindlar's catalyst In methanol for 10h;88%
With hydrogen; Lindlar's catalyst In methanol Ambient temperature;86%
succinic acid anhydride
108-30-5

succinic acid anhydride

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

artesunate
88495-63-0

artesunate

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; cation exchange resin In tetrahydrofuran at 20 - 35℃; for 0.666667h;
Stage #2: succinic acid anhydride With triethylamine In tetrahydrofuran at 20 - 35℃; for 1h;
96%
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; D-glucose In 1,4-dioxane at 20 - 30℃; for 2h;
Stage #2: succinic acid anhydride In 1,4-dioxane at 20 - 30℃; for 2h;
93%
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; cation exchange resin In tetrahydrofuran at 20 - 35℃; for 0.75h;
Stage #2: succinic acid anhydride With sodium hydrogencarbonate In tetrahydrofuran at 20 - 35℃; for 1.25h;
93%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

7β-hydroxyartemisinin

7β-hydroxyartemisinin

Conditions
ConditionsYield
With sodium phosphite; phosphite dehydrogenase; P450 variant IV-H4; oxygen; nicotinamide adenine dinucleotide phosphate In aq. phosphate buffer at 20℃; for 12h; pH=8; Reagent/catalyst; Time;92%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

9α-hydroxyartemisinin

9α-hydroxyartemisinin

Conditions
ConditionsYield
With sodium phosphite; phosphite dehydrogenase; P450 variant II-H10; oxygen; nicotinamide adenine dinucleotide phosphate In aq. phosphate buffer at 20℃; for 12h; pH=8;91%
methanol
67-56-1

methanol

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

A

(R)-2-((1R,4S,4aR,7R,9aS)-4a-Formyl-7-hydroxy-1,7-dimethyl-octahydro-5,6-dioxa-benzocyclohepten-4-yl)-propionic acid methyl ester
95851-77-7

(R)-2-((1R,4S,4aR,7R,9aS)-4a-Formyl-7-hydroxy-1,7-dimethyl-octahydro-5,6-dioxa-benzocyclohepten-4-yl)-propionic acid methyl ester

B

(R)-2-[(1S,3S,4R)-4-Methyl-2-oxo-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester
103740-01-8

(R)-2-[(1S,3S,4R)-4-Methyl-2-oxo-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid for 0.166667h;A n/a
B 90%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

acetyl chloride
75-36-5

acetyl chloride

dihydroartemisinin acetate
75887-51-3

dihydroartemisinin acetate

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate
Stage #2: acetyl chloride With pyridine
90%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

6a-hydroxy-artemisinin

6a-hydroxy-artemisinin

Conditions
ConditionsYield
With sodium phosphite; phosphite dehydrogenase; P450 variant X-F11; oxygen; nicotinamide adenine dinucleotide phosphate In aq. phosphate buffer at 20℃; for 12h; pH=8; Reagent/catalyst; Time;90%
dehydroqinghaosu
101020-89-7

dehydroqinghaosu

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

C30H42O10

C30H42O10

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 0.75h;
Stage #2: dehydroqinghaosu In tetrahydrofuran at -78℃; for 5h; Further stages.;
88%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

(trifluoromethyl)trimethylsilane
81290-20-2

(trifluoromethyl)trimethylsilane

(1S,4R,5R,8R,9R,10R,12R,13R)-1,5,9-trimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol
185418-56-8

(1S,4R,5R,8R,9R,10R,12R,13R)-1,5,9-trimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran for 25h; Ambient temperature;87%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

A

(3aS,4R,6aS,7R,10S,10aR)-10-(acetyloxy)octahydro-4,7-dimethyl-8H,10H-furo[3,2-i][2]benzopyran-8-one
98379-74-9

(3aS,4R,6aS,7R,10S,10aR)-10-(acetyloxy)octahydro-4,7-dimethyl-8H,10H-furo[3,2-i][2]benzopyran-8-one

B

(3R,3aS,6R,6aS,8R,9S,10aS,10bR)-octahydro-8-hydroxy-3,6,9-trimethyl-10aH-9,10b-epoxypyrano[4,3,2-jk][2]benzoxepin-2(3H)-one

(3R,3aS,6R,6aS,8R,9S,10aS,10bR)-octahydro-8-hydroxy-3,6,9-trimethyl-10aH-9,10b-epoxypyrano[4,3,2-jk][2]benzoxepin-2(3H)-one

Conditions
ConditionsYield
With pyridine; iron(III) chloride In acetonitrile for 36h;A 85%
B 8%
With meso-tetraphenylporphyrin iron(III) chloride; N-acetylcystein In dichloromethane for 0.75h;A 74%
B n/a
With 1H-imidazole; iron(III) trifluoromethanesulfonate; N-acetylcystein In acetonitrile for 18h;A 41%
B 50%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

9-fluoroartemisinin
1037585-91-3

9-fluoroartemisinin

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With lithium diisopropyl amide In tetrahydrofuran at -78℃; for 1h;
Stage #2: With N-fluorobenzene sulfonamide In tetrahydrofuran at -78℃; for 1h; Further stages.;
85%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

allyl halogenide

allyl halogenide

(3R,6R,9S,12S,12aR)-9-allyl-3,6,9-trimethyloctahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10(3H)-one

(3R,6R,9S,12S,12aR)-9-allyl-3,6,9-trimethyloctahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10(3H)-one

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78℃; for 0.5h; Inert atmosphere;
Stage #2: With N,N,N,N,N,N-hexamethylphosphoric triamide In tetrahydrofuran; hexane at -78℃; Inert atmosphere;
Stage #3: allyl halogenide With diethylzinc In tetrahydrofuran; hexane at -78 - 20℃; Inert atmosphere;
82%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

(trifluoromethyl)trimethylsilane
81290-20-2

(trifluoromethyl)trimethylsilane

trimethylsilyl (1S,4R,5R,8R,9R,10R,12S,13R)-1,5,9-trimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.0.4,1308,13]hexadec-10-yl ether
405261-71-4

trimethylsilyl (1S,4R,5R,8R,9R,10R,12S,13R)-1,5,9-trimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1.0.4,1308,13]hexadec-10-yl ether

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride In tetrahydrofuran at 0 - 20℃; for 7h;79%
propan-1-ol
71-23-8

propan-1-ol

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

C18H30O5

C18H30O5

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; amberlyst-15 In tetrahydrofuran at 20℃; for 0.5h;
Stage #2: propan-1-ol In dichloromethane at 20℃; for 72h;
79%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

A

(3aS,4R,6aS,7R,10S,10aR)-10-(acetyloxy)octahydro-4,7-dimethyl-8H,10H-furo[3,2-i][2]benzopyran-8-one
98379-74-9

(3aS,4R,6aS,7R,10S,10aR)-10-(acetyloxy)octahydro-4,7-dimethyl-8H,10H-furo[3,2-i][2]benzopyran-8-one

B

3α-hydroxydeoxyartemisinin

3α-hydroxydeoxyartemisinin

Conditions
ConditionsYield
With iron(II) chloride In acetonitrile for 0.0333333h; Mechanism; Ambient temperature;A 78%
B 17%
With iron(II) chloride In acetonitrile for 0.25h; Ambient temperature;A 78%
B 17%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

2-deuteriodihydroqinghaosu

2-deuteriodihydroqinghaosu

Conditions
ConditionsYield
With sodium borodeuteride In methanol for 1h; Reduction;77%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

(trifluoromethyl)trimethylsilane
81290-20-2

(trifluoromethyl)trimethylsilane

C16H23F3O5

C16H23F3O5

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO); (trifluoromethyl)trimethylsilane With tetrabutyl ammonium fluoride In tetrahydrofuran at 0℃; for 2h;
Stage #2: With water at 20℃; for 0.5h; Further stages.;
77%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

(R)-2-[(1S,3S,4R)-4-Methyl-2-oxo-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester
103740-01-8

(R)-2-[(1S,3S,4R)-4-Methyl-2-oxo-3-(3-oxo-butyl)-cyclohexyl]-propionic acid methyl ester

Conditions
ConditionsYield
With sulfuric acid In methanol75%
With iron(III) chloride In diethyl ether for 1.5h;
With trifluoroacetic acid In methanol Heating;
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

10-deoxoartemisinin

10-deoxoartemisinin

Conditions
ConditionsYield
With sodium tetrahydroborate; boron trifluoride diethyl etherate In tetrahydrofuran75%
Multi-step reaction with 2 steps
1: 100 percent / DIBAL-H / CH2Cl2 / 1.25 h / -78 °C
2: 1.) Et3SiH, 2.) BF3*OEt2 / 1.) CH2Cl2, -78 deg C, 10 min, 2.) CH2Cl2, -78 deg C, 3 h
View Scheme
pentan-1-ol
71-41-0

pentan-1-ol

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

C20H34O5

C20H34O5

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; amberlyst-15 In tetrahydrofuran at 20℃; for 0.5h;
Stage #2: pentan-1-ol In dichloromethane at 20℃; for 56h;
74%
C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

ethylene glycol
107-21-1

ethylene glycol

C18H30O6

C18H30O6

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In benzene for 17h; Reflux;74%
methanol
67-56-1

methanol

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

(R)-methyl 2-((3R,6R,9aR)-9a-formyl-3-methoxy-3,6-dimethyloctahydro-3H-benzo[c][1,2]dioxepin-9-yl)propanoate
95851-75-5

(R)-methyl 2-((3R,6R,9aR)-9a-formyl-3-methoxy-3,6-dimethyloctahydro-3H-benzo[c][1,2]dioxepin-9-yl)propanoate

Conditions
ConditionsYield
With trifluoroacetic acid for 5h; Reflux;73%
With sulfuric acid for 3h; Yield given;
Butane-1,4-diol
110-63-4

Butane-1,4-diol

C12H13O2(CH3)3(O)(OO)
63968-64-9

C12H13O2(CH3)3(O)(OO)

C19H32O6

C19H32O6

Conditions
ConditionsYield
Stage #1: C12H13O2(CH3)3(O)(OO) With sodium tetrahydroborate; amberlyst-15 In tetrahydrofuran at 20℃; for 0.5h;
Stage #2: Butane-1,4-diol In dichloromethane at 20℃; for 55h;
73%

Artemisinin Chemical Properties

Molecular Structure: 
Molecular Formula: C15H22O5
Molecular Weight: 282.33 
CAS NO: 63968-64-9
H bond acceptors: 5
H bond donors: 0
Freely Rotating Bonds: 0
Polar Surface Area: 53.99 Å2
Index of Refraction: 1.533
Molar Refractivity: 70.31 cm3
Molar Volume: 226.4 cm
Surface Tension: 43.5 dyne/cm
Density: 1.24 g/cm3
Flash Point: 172 °C
Enthalpy of Vaporization: 63.93 kJ/mol
Boiling Point: 389.9 °C at 760 mmHg
Vapour Pressure: 2.76E-06 mmHg at 25°C
Melting point: 156-157 °C(lit.)
Alpha: 76 o (c=0.5,MeOH)
Appearance: Crystalline Solid
Stability: Stable. Combustible. Incompatible with strong oxidizing agents, acids, acid chlorides, acid anhydrides. May absorb, and react with, carbon dioxide from the air. 
Product Categories of Artemisinin (CAS NO.63968-64-9): Active Pharmaceutical Ingredients;Miscellaneous Natural Products;Others (Antibiotics for Research and Experimental Use);Antibiotics for Research and Experimental Use;Biochemistry;Standard extract;Natural Plant Extract;Intermediates & Fine Chemicals;Pharmaceuticals;Miscellaneous Compounds

Artemisinin Uses

 Artemisinin (CAS NO.63968-64-9) is derived from a herb used in Chinese traditional medicine, though it is usually chemically modified and combined with other medications.Combination therapies that include artemisinin are the preferred treatment for malaria and are both effective and well tolerated in patients. It is also being studied as a treatment for cancer.

Artemisinin Production

 Artemisinin (CAS NO.63968-64-9) is isolated from the plant Artemisia annua. It is only produced when the plant is subjected to certain conditions, most likely biotic or abiotic stress.
Here is biosynthesis of Artemisinin .

Artemisinin Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD intramuscular > 800mg/kg (800mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Traditional Chinese Medicine Vol. 2, Pg. 31, 1982.
mouse LD unreported > 2gm/kg (2000mg/kg)   Antimicrobial Agents and Chemotherapy. Vol. 37, Pg. 1108, 1993.
mouse LD50 intramuscular 2800mg/kg (2800mg/kg)   Chinese Medical Journal Vol. 92, Pg. 811, 1979.
mouse LD50 intraperitoneal 1558mg/kg (1558mg/kg)   Chinese Medical Journal Vol. 92, Pg. 811, 1979.
mouse LD50 oral 4228mg/kg (4228mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: TREMOR

BEHAVIORAL: ATAXIA
Journal of Traditional Chinese Medicine Vol. 2, Pg. 31, 1982.
rat LD50 intramuscular 2571mg/kg (2571mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: TREMOR

BEHAVIORAL: ATAXIA
Journal of Traditional Chinese Medicine Vol. 2, Pg. 31, 1982.
rat LD50 oral 5576mg/kg (5576mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: TREMOR

BEHAVIORAL: ATAXIA
Journal of Traditional Chinese Medicine Vol. 2, Pg. 31, 1982.

Artemisinin Safety Profile

Safety Information about Artemisinin (CAS NO.63968-64-9):
Safety Statements: 22-24/25
22: Do not breathe dust
24/25: Avoid contact with skin and eyes 
WGK Germany: 2
Moderately toxic by ingestion, intramuscular, and intraperitoneal routes. When heated to decomposition it emits acrid smoke and fumes.

Artemisinin Specification

 Artemisinin (CAS NO.63968-64-9) is also called (+)-Arteannuin ; Qinghaosu  and [3R-(3R,5aS,6S,8aS,9R,10R,12S,12aR**)]-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-one  .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View